242 related articles for article (PubMed ID: 19331812)
1. Ornithine decarboxylase regulates the activity and localization of rhoA via polyamination.
Mäkitie LT; Kanerva K; Andersson LC
Exp Cell Res; 2009 Apr; 315(6):1008-14. PubMed ID: 19331812
[TBL] [Abstract][Full Text] [Related]
2. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells.
Kucharzewska P; Welch JE; Svensson KJ; Belting M
Exp Cell Res; 2010 Oct; 316(16):2683-91. PubMed ID: 20594968
[TBL] [Abstract][Full Text] [Related]
4. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.
Moshier JA; Dosescu J; Skunca M; Luk GD
Cancer Res; 1993 Jun; 53(11):2618-22. PubMed ID: 8495425
[TBL] [Abstract][Full Text] [Related]
5. High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation.
Hobbs CA; Gilmour SK
J Cell Biochem; 2000 Apr; 77(3):345-60. PubMed ID: 10760944
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
7. Relationship between ornithine decarboxylase and cytoskeletal organization in cultured human keratinocytes: cellular responses to phorbol esters, cytochalasins, and alpha-difluoromethylornithine.
Pomidor MM; Ruhl KK; Zheng P; Song Y; Jänne OA; Tuan RS; Hickok NJ
Exp Cell Res; 1995 Dec; 221(2):426-37. PubMed ID: 7493642
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
9. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
[TBL] [Abstract][Full Text] [Related]
10. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
Shantz LM; Hu RH; Pegg AE
Cancer Res; 1996 Jul; 56(14):3265-9. PubMed ID: 8764119
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of TGFbeta on proliferation of 7- and 14-day-old chick embryo fibroblasts and lack of involvement of the ODC/PA system in the TGFbeta signaling pathway.
Evangelisti R; Valeno V; Bosi G; Baroni T; Bellucci C; Carinci P
J Cell Physiol; 1999 Mar; 178(3):304-10. PubMed ID: 9989776
[TBL] [Abstract][Full Text] [Related]
12. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
Nilsson J; Grahn B; Heby O
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.
Cañizares F; Salinas J; de las Heras M; Diaz J; Tovar I; Martinez P; Peñafiel R
Clin Cancer Res; 1999 Aug; 5(8):2035-41. PubMed ID: 10473083
[TBL] [Abstract][Full Text] [Related]
14. Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton.
Coleman ML; Densham RM; Croft DR; Olson MF
Oncogene; 2006 May; 25(19):2708-16. PubMed ID: 16407839
[TBL] [Abstract][Full Text] [Related]
15. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
Keren-Paz A; Bercovich Z; Kahana C
Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
[TBL] [Abstract][Full Text] [Related]
16. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation.
Shantz LM; Coleman CS; Pegg AE
Cancer Res; 1996 Nov; 56(22):5136-40. PubMed ID: 8912847
[TBL] [Abstract][Full Text] [Related]
17. Translocation of ornithine decarboxylase to the surface membrane during cell activation and transformation.
Heiskala M; Zhang J; Hayashi S; Hölttä E; Andersson LC
EMBO J; 1999 Mar; 18(5):1214-22. PubMed ID: 10064588
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
[TBL] [Abstract][Full Text] [Related]
19. Effect of retinoic acid on transglutaminase and ornithine decarboxylase activities during liver regeneration.
Ohtake Y; Maruko A; Ohishi N; Kawaguchi M; Satoh T; Ohkubo Y
Cell Biochem Funct; 2008 Apr; 26(3):359-65. PubMed ID: 18008394
[TBL] [Abstract][Full Text] [Related]
20. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
